Related references
Note: Only part of the references are listed.Rational design and Structure-Activity relationship of coumarin derivatives effective on HIV-1 protease and partially on HIV-1 reverse transcriptase
Mei Zhu et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)
Coronavirus Infections-More Than Just the Common Cold
Catharine I. Paules et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Coumarin-containing hybrids and their antibacterial activities
Dongxu Feng et al.
ARCHIV DER PHARMAZIE (2020)
Herpes simplex virus: global infection prevalence and incidence estimates, 2016
Charlotte James et al.
BULLETIN OF THE WORLD HEALTH ORGANIZATION (2020)
Natural Products as Sources of New Drugs over the Nearly Four Decades from 01/1981 to 09/2019
David J. Newman et al.
JOURNAL OF NATURAL PRODUCTS (2020)
Alphavirus capsid protease inhibitors as potential antiviral agents for Chikungunya infection
Benazir Fatma et al.
ANTIVIRAL RESEARCH (2020)
Imperatorin: A review of its pharmacology, toxicity and pharmacokinetics
Mao Deng et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2020)
Cytosolic DNA-sensing immune response and viral infection
Takayuki Abe et al.
MICROBIOLOGY AND IMMUNOLOGY (2019)
Screening for inhibitor of episomal DNA identified dicumarol as a hepatitis B virus inhibitor
Fumihiko Takeuchi et al.
PLOS ONE (2019)
Synthesis and antiviral activity of coumarin derivatives against infectious hematopoietic necrosis virus
Yang Hu et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2019)
Chronic Hepatitis E is associated with cholangitis
Andrea Beer et al.
LIVER INTERNATIONAL (2019)
Increase in Hepatitis A Virus Infections - United States, 2013-2018
Monique A. Foster et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2019)
Role of medicinal plants in HIV/AIDS therapy
Umme Laila et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2019)
Potential Drug Targets Against Hepatitis B Virus Based on Both Virus and Host Factors
Bing-Yi Zhang et al.
CURRENT DRUG TARGETS (2019)
Mapping the Interactions of HBV cccDNA with Host Factors
Nur K. Mohd-Ismail et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Anti-Hepatitis B Virus Activity of Esculetin from Microsorium fortunei In Vitro and In Vivo
Si-Xin Huang et al.
MOLECULES (2019)
Vpr Enhances HIV-1 Env Processing and Virion Infectivity in Macrophages by Modulating TET2-Dependent IFITM3 Expression
Qi Wang et al.
MBIO (2019)
Functionalized selenium nanoparticles enhance the anti-EV71 activity of oseltamivir in human astrocytoma cell model
Jiayu Zhong et al.
ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY (2019)
Chromenone derivatives as a versatile scaffold with dual mode of inhibition of HIV-1 reverse transcriptase-associated Ribonuclease H function and integrase activity
Francesca Esposito et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
Prenylated Coumarins from the Fruits of Manilkara zapota with Potential Anti-inflammatory Effects and Anti-HIV Activities
Yan-Ping Liu et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2019)
Characterization of polyclonal antibodies to herpes simplex virus types 1 and 2
Joshua Lloyd et al.
JOURNAL OF HISTOTECHNOLOGY (2019)
Synthetically modified methoxsalen for enhanced cytotoxicity in light and dark reactions
Christophe D. Guillon et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2019)
Hepatitis C - New drugs and treatment prospects
Marianna Zajac et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
Chikungunya virus inhibition by synthetic coumarin-guanosine conjugates
Jih Ru Hwu et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
Serum Hepatitis B Virus RNA: A New Potential Biomarker for Chronic Hepatitis B Virus Infection
Shi Liu et al.
HEPATOLOGY (2019)
Viral Hepatitis Etiology, Epidemiology, Transmission, Diagnostics, Treatment, and Prevention
Simone Lanini et al.
INFECTIOUS DISEASE CLINICS OF NORTH AMERICA (2019)
Predicting Intraserotypic Recombination in Enterovirus 71
Andrew Woodman et al.
JOURNAL OF VIROLOGY (2019)
Unexpected mode of engagement between enterovirus 71 and its receptor SCARB2
Daming Zhou et al.
NATURE MICROBIOLOGY (2019)
In vitro methods for testing antiviral drugs
Michaela Rumlova et al.
BIOTECHNOLOGY ADVANCES (2018)
Bis-coumarin Derivatives and their Biological Activities
Qing-Cheng Ren et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2018)
Vpr Targets TET2 for Degradation by CRL4(VprBP) E3 Ligase to Sustain IL-6 Expression and Enhance HIV-1 Replication
Lei Lv et al.
MOLECULAR CELL (2018)
Affinity switching of the LEDGF/p75 IBD interactome is governed by kinase-dependent phosphorylation
Subhalakshmi Sharma et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Antiviral effect of compounds derived from Angelica archangelica L. on Herpes simplex virus-1 and Coxsackievirus B3 infections
Barbara Rajtar et al.
FOOD AND CHEMICAL TOXICOLOGY (2017)
HIV drug resistance testing among patients failing second line antiretroviral therapy. Comparison of in-house and commercial sequencing
Benjamin Chimukangara et al.
JOURNAL OF VIROLOGICAL METHODS (2017)
Cnidimonins A-C, Three Types of Hybrid Dimer from Cnidium monnieri: Structural Elucidation and Semisynthesis
Fangyi Su et al.
ORGANIC LETTERS (2017)
Human immunodeficiency virus: Diagnostic approach
Jeannette Guarner
SEMINARS IN DIAGNOSTIC PATHOLOGY (2017)
Future technologies for monitoring HIV drug resistance and cure
Urvi M. Parikh et al.
CURRENT OPINION IN HIV AND AIDS (2017)
Metabolism of F18, a Derivative of Calanolide A, in Human Liver Microsomes and Cytosol
Xiangmeng Wu et al.
FRONTIERS IN PHARMACOLOGY (2017)
Anti-influenza activity of monoterpene-containing substituted coumarins
Tatyana M. Khomenko et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2017)
Discovery of 3-benzyl-1,3-benzoxazine-2,4-dione analogues as allosteric mitogen-activated kinase kinase (MEK) inhibitors and anti-enterovirus 71 (EV71) agents
Jing Sun et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2016)
Approved Antiviral Drugs over the Past 50 Years
Erik De Clercq et al.
CLINICAL MICROBIOLOGY REVIEWS (2016)
Why Do We Need New Drug Classes for HIV Treatment and Prevention?
Abdul A. Waheed et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2016)
Relationship between coumarin-induced hepatocellular toxicity and mitochondrial function in rats
Yasuhiro Tanaka et al.
FOOD AND CHEMICAL TOXICOLOGY (2016)
Rational Design, Synthesis and Evaluation of Coumarin Derivatives as Protein-protein Interaction Inhibitors
Laura De Luca et al.
MOLECULAR INFORMATICS (2016)
Synthesis and Structure-Activity Relationships of Imidazole-Coumarin Conjugates against Hepatitis C Virus
Shwu-Chen Tsay et al.
MOLECULES (2016)
HCV and Oxidative Stress: Implications for HCV Life Cycle and HCV-Associated Pathogenesis
Regina Medvedev et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2016)
Benzouracil-coumarin-arene conjugates as inhibiting agents for chikungunya virus
Jih Ru Hwu et al.
ANTIVIRAL RESEARCH (2015)
Inhibition of HIV-1 entry by the tricyclic coumarin GUT-70 through the modification of membrane fluidity
Kouki Matsuda et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2015)
A coumarin lignanoid from the stems of Kadsura heteroclita
Wei Su et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2015)
Two new coumarin glycosides from Herpetospermum caudigerum
Bing Xu et al.
JOURNAL OF ASIAN NATURAL PRODUCTS RESEARCH (2015)
Chikungunya Virus and the Global Spread of a Mosquito-Borne Disease
Scott C. Weaver et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Mechanisms of Hepatitis C Viral Resistance to Direct Acting Antivirals
Asma Ahmed et al.
VIRUSES-BASEL (2015)
Novel furocoumarins as potential HIV-1 integrase inhibitors
Temitope O. Olomola et al.
BIOORGANIC CHEMISTRY (2014)
Synthesis and evaluation of coumarin derivatives as potential dual-action HIV-1 protease and reverse transcriptase inhibitors
Temitope O. Olomola et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2013)
Inhibition of HIV-1 replication by a tricyclic coumarin GUT-70 in acutely and chronically infected cells
Eriko Kudo et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2013)
Coumarins hinged directly on benzimidazoles and their ribofuranosides to inhibit hepatitis C virus
Shwu-Chen Tsay et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2013)
Substituted 3-Benzylcoumarins as Allosteric MEK1 Inhibitors: Design, Synthesis and Biological Evaluation as Antiviral Agents
Chao Wang et al.
MOLECULES (2013)
MEK1-ERKs signal cascade is required for the replication of Enterovirus 71 (EV71)
Bo Wang et al.
ANTIVIRAL RESEARCH (2012)
Lignans from the heartwood of Streblus asper and their inhibiting activities to Hepatitis B virus
Lu-Qing Li et al.
FITOTERAPIA (2012)
3-Phenylcoumarins as Inhibitors of HIV-1 Replication
Dionisio Olmedo et al.
MOLECULES (2012)
Inhibition of HIV-1 reverse transcriptase, toxicological and chemical profile of Calophyllum brasiliense extracts from Chiapas, Mexico
Garcia-Zebadua Julio Cesar et al.
FITOTERAPIA (2011)
Vipirinin, a Coumarin-based HIV-1 Vpr Inhibitor, Interacts with a Hydrophobic Region of VPR
Eugene Boon Beng Ong et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Coumarin-Purine Ribofuranoside Conjugates as New Agents against Hepatitis C Virus
Jih Ru Hwu et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
Inhibition of HIV-1 Tat-Mediated Transcription by a Coumarin Derivative, BPRHIV001, through the Akt Pathway
Pi-Han Lin et al.
JOURNAL OF VIROLOGY (2011)
Benzylidene-bis-(4-Hydroxycoumarin) and Benzopyrano-Coumarin Derivatives: Synthesis, 1H/13C-NMR Conformational and X-ray Crystal Structure Studies and In Vitro Antiviral Activity Evaluations
Davorka Zavrsnik et al.
MOLECULES (2011)
Highly Suppressing Wild-Type HIV-1 and Y181C Mutant HIV-1 Strains by 10-Chloromethyl-11-demethyl-12-oxo-calanolide A with Druggable Profile
Hai Xue et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Synthesis and Studies of New 2-(Coumarin-4-yloxy)-4,6-(substituted)-s-Triazine Derivatives as Potential Anti-HIV Agents
Dharmesh H. Mahajan et al.
ARCHIV DER PHARMAZIE (2009)
Hepatitis B: The Virus and Disease
T. Jake Liang
HEPATOLOGY (2009)
Control of cccDNA function in hepatitis B virus infection
Massimo Levrero et al.
JOURNAL OF HEPATOLOGY (2009)
Structure-Activity Relationship of New Anti-Hepatitis C Virus Agents: Heterobicycle-Coumarin Conjugates
Johan Neyts et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
7-O-Methylkaempferol and -quercetin Glycosides from the Whole Plant of Nervilia fordii
Li-Wen Tian et al.
JOURNAL OF NATURAL PRODUCTS (2009)
Synthesis of new benzimidazole-coumarin conjugates as anti-hepatitis C virus agents
Jih Ru Hwu et al.
ANTIVIRAL RESEARCH (2008)
Synthesis and HIV-1 integrase inhibition of novel bis- or tetra-coumarin analogues
Chih-Chia Chiang et al.
CHEMICAL & PHARMACEUTICAL BULLETIN (2007)
Natural products to drugs: natural product derived compounds in clinical trials (vol 22, pg 162, 2005)
MS Butler
NATURAL PRODUCT REPORTS (2006)
Identification of coumarin derivatives as a novel class of allosteric MEK1 inhibitors
SL Han et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2005)
Anti-AIDS agents 65:: Investigation of the in vitro oxidative metabolism of 3′,4′-Di-O-(-)-camphanoyl-(+)-cis-khellactone derivatives as potent anti-HIV agents
M Suzuki et al.
DRUG METABOLISM AND DISPOSITION (2005)
Mesuol, a natural occurring 4-phenylcoumarin, inhibits HTV-1 replication by targeting the NF-κB pathway
N Márquez et al.
ANTIVIRAL RESEARCH (2005)
Mechanism of action and resistant profile of anti-HIV-1 coumarin derivatives
L Huang et al.
VIROLOGY (2005)
Natural products to drugs: natural product derived compounds in clinical trials
MS Butler
NATURAL PRODUCT REPORTS (2005)
Anti-AIDS agents.: 52.: Synthesis and anti-HIV activity of hydroxymethyl (3′R,4′R)-3′,4′-di-O-(S)-camphanoyl-(+)-cis-khellactone derivatives
L Xie et al.
JOURNAL OF MEDICINAL CHEMISTRY (2004)
Imperatorin inhibits HIV-1 replication through an Sp1-dependent pathway
R Sancho et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Anti-AIDS agents.: Part 56:: Synthesis and anti-HIV activity of 7-thia-di-O-(-)-camphanoyl-(+)-cis-khellactone (7-thia-DCK) analogs
Y Chen et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2004)
Anti-AIDS agents.: 60.† substituted 3′R,4′R-Di-O-(-)-camphanoyl-2′,2′-dimethyldihydropyrano[2,3-f]chromone (DCP) analogues as potent anti-HIV agents
DL Yu et al.
JOURNAL OF MEDICINAL CHEMISTRY (2004)
Anti-HIV agents.: Part 55:: 3′R,4′R-di-(O)-(-)-camphanoyl-2′,2′-dimethyldihydropyrano[2,3-f]chromone (DCP), a novel anti-HIV agent
DL Yu et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2003)
Chemical modification of coumarin dimer and HIV-1 integrase inhibitory activity
PCM Mao et al.
CHEMICAL & PHARMACEUTICAL BULLETIN (2002)
Anti-AIDS agents.: Part 47:: Synthesis and anti-HIV activity of 3-substituted 3′,4′-di-O-(S)-camphanoyl-(3′R,4′R)-(+)-cis-khellactone derivatives
L Xie et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2001)
Chemical constituents of Prangos tschimganica;: Structure elucidation and absolute configuration of coumarin and furanocoumarin derivatives with anti-HIV activity
Y Shikishima et al.
CHEMICAL & PHARMACEUTICAL BULLETIN (2001)
Anti-AIDS agents.: 42.: Synthesis and anti-HIV activity of disubstituted (3′R,4′R)-3′,4′-di-O-(S)-camphanoyl-(+)-cis-khellactone analogues
L Xie et al.
JOURNAL OF MEDICINAL CHEMISTRY (2001)
Anti-AIDS agents part 41:: Synthesis and anti-HIV activity of 3′,4′-di-o-(-)-camphanoyl-(+)-cis-khellactone (DCK) lactam analogues
ZY Yang et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2000)